Evidence map›Paper›PMID 35746787›Full record

ArticleViruses2022

SARS-CoV-2 Delta Variant N Gene Mutations Reduce Sensitivity to the TaqPath COVID-19 Multiplex Molecular Diagnostic Assay.

Steven C Holland, Ajeet Bains, LaRinda A Holland, Matthew F Smith, Regan A Sullins, Nicholas J Mellor, Alexis W Thomas, Nathaniel Johnson, Vel Murugan, Efrem S Lim

Abstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Steven C HollandCenter for Fundamental and Applied Microbiomics, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.ORCID 0000-0003-0649-3611
Ajeet BainsCenter for Fundamental and Applied Microbiomics, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.
LaRinda A HollandCenter for Fundamental and Applied Microbiomics, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.
Matthew F SmithCenter for Fundamental and Applied Microbiomics, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.
Regan A SullinsCenter for Fundamental and Applied Microbiomics, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.
Nicholas J MellorCenter for Fundamental and Applied Microbiomics, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.
Alexis W ThomasCenter for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.
Nathaniel JohnsonCenter for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.
Vel MuruganCenter for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.
Efrem S LimCenter for Fundamental and Applied Microbiomics, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.ORCID 0000-0002-3397-9310

Funding

CDC HHS CDC BAA 75D30121C11084
6 · The paper itself

Abstract

As the SARS-CoV-2 virus evolves, mutations may result in diminished sensitivity to qRT-PCR diagnostic assays. We investigated four polymorphisms circulating in the SARS-CoV-2 Delta lineage that result in

Indexed as

COVID-19SARS-CoV-2HumansMutationPathology, MolecularSensitivity and SpecificityCOVID-19delta variantN gene dropoutqRT-PCRSARS-CoV-2

Identifiers

PMID35746787
PMCPMC9228125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.